Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D'Erasmo

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Lipidology|June 10, 2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety dataMarcello Arca, Laura D'Erasmo, Marina Cuchel, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 25, 2020
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational studyLaura D'Erasmo, Daniela Commodari, Alessia Di Costanzo, et al.
Journal of Lipid Research|October 1, 2020
Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohortChiara Pavanello, Alice Ossoli, Marcello Arca, et al.
Clinical and Experimental Immunology|January 12, 2022
The role of lipid metabolism in shaping the expansion and the function of regulatory T cellsAlessandra Pinzon Grimaldos, Simone Bini, Ilenia Pacella, et al.
European Journal of Preventive Cardiology|December 31, 2021
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational studyLaura D'Erasmo, Kim Steward, Angelo Baldassare Cefalù, et al.
Biomolecules|April 23, 2022
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk PathwaySimone Bini, Valeria Pecce, Alessia Di Costanzo, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|December 15, 2022
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasisAlice Ossoli, Ilenia Minicocci, Marta Turri, et al.
Pediatric Research|February 3, 2019
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesityAlessia Di Costanzo, Lucia Pacifico, Claudio Chiesa, et al.
International Journal of Molecular Sciences|September 12, 2019
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese ChildrenAlessia Di Costanzo, Lucia Pacifico, Laura D'Erasmo, et al.
British Journal of Clinical Pharmacology|June 16, 2021
Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysisDaniele Pastori, Arianna Pani, Arianna Di Rocco, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Lipidology|June 10, 2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety dataMarcello Arca, Laura D'Erasmo, Marina Cuchel, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 25, 2020
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational studyLaura D'Erasmo, Daniela Commodari, Alessia Di Costanzo, et al.
Journal of Lipid Research|October 1, 2020
Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohortChiara Pavanello, Alice Ossoli, Marcello Arca, et al.
Clinical and Experimental Immunology|January 12, 2022
The role of lipid metabolism in shaping the expansion and the function of regulatory T cellsAlessandra Pinzon Grimaldos, Simone Bini, Ilenia Pacella, et al.
European Journal of Preventive Cardiology|December 31, 2021
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational studyLaura D'Erasmo, Kim Steward, Angelo Baldassare Cefalù, et al.
Biomolecules|April 23, 2022
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk PathwaySimone Bini, Valeria Pecce, Alessia Di Costanzo, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|December 15, 2022
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasisAlice Ossoli, Ilenia Minicocci, Marta Turri, et al.
Pediatric Research|February 3, 2019
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesityAlessia Di Costanzo, Lucia Pacifico, Claudio Chiesa, et al.
International Journal of Molecular Sciences|September 12, 2019
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese ChildrenAlessia Di Costanzo, Lucia Pacifico, Laura D'Erasmo, et al.
British Journal of Clinical Pharmacology|June 16, 2021
Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysisDaniele Pastori, Arianna Pani, Arianna Di Rocco, et al.
Pageof 8